Oxbridge Re Holdings Limited (NASDAQ:OXBR – Get Free Report) was the recipient of a significant drop in short interest during the month of July. As of July 15th, there was short interest totaling 6,687 shares, a drop of 72.5% from the June 30th total of 24,328 shares. Based on an average daily volume of 76,661 shares, the short-interest ratio is currently 0.1 days. Approximately 0.1% of the company’s shares are short sold.
Hedge Funds Weigh In On Oxbridge Re
A number of institutional investors have recently bought and sold shares of the stock. Virtu Financial LLC bought a new stake in Oxbridge Re during the 3rd quarter valued at approximately $32,000. International Assets Investment Management LLC bought a new position in shares of Oxbridge Re in the 4th quarter worth approximately $39,000. Finally, J.W. Cole Advisors Inc. raised its position in shares of Oxbridge Re by 106.1% in the 4th quarter. J.W. Cole Advisors Inc. now owns 68,000 shares of the insurance provider’s stock worth $90,000 after acquiring an additional 35,000 shares in the last quarter. 5.64% of the stock is owned by institutional investors.
Oxbridge Re Price Performance
Oxbridge Re stock remained flat at $1.57 during mid-day trading on Monday. 14,874 shares of the company’s stock were exchanged, compared to its average volume of 52,223. The company has a debt-to-equity ratio of 0.16, a current ratio of 8.15 and a quick ratio of 8.15. The stock’s 50-day moving average price is $1.17 and its 200 day moving average price is $1.06. The stock has a market capitalization of $12.72 million, a price-to-earnings ratio of -6.28 and a beta of 2.01. Oxbridge Re has a fifty-two week low of $0.66 and a fifty-two week high of $2.86.
Analyst Upgrades and Downgrades
Get Our Latest Stock Analysis on Oxbridge Re
About Oxbridge Re
Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.
The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.
Further Reading
- Five stocks we like better than Oxbridge Re
- AirJoule’s Kubota Deal Is a Major Validation—But the Hard Part Comes Next
- Dividend Stocks May Be the Quiet Rotation Trade Investors Are Missing Now
- Refiner Stocks Are Near Record Highs—Can Iran-Driven Margins Keep Them There?
- Verizon May Be an AI Infrastructure Stock Hiding in Plain Sight
Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.
